On the optimization of cholesterol screening

Area of Science:

• Cardiovascular Disease Research
• Health Economics
• Public Health Screening

Background:

• Total serum cholesterol is a significant risk factor for Coronary Heart Disease (CHD).
• Existing guidelines address cholesterol treatment levels, but cost-benefit analyses for screening are needed.
• Implementing cholesterol screening requires careful evaluation of costs versus benefits at various cholesterol levels.

Purpose of the Study:

• To analyze the costs and benefits of a cholesterol screening-intervention program.
• To determine the optimal cholesterol level range for cost-effective screening.
• To utilize microcomputer spreadsheets and decision tree analysis for preliminary cost-benefit estimation.

Main Methods:

• Decision tree analysis performed on microcomputer spreadsheets.
• Sensitivity analysis employed due to difficulties in satisfactorily establishing all costs.
• Plausible numerical values used as default conditions for estimation.

Main Results:

• The cost-benefit analysis indicates an optimal condition for screening within the cholesterol level range of 200-240 mg/dl.
• The optimal cost-benefit condition remains stable across this range under default parameter values.
• Altering default parameter values can significantly shift the optimal screening condition.
• The maximal net benefit, using default values, approximates 5% of estimated current CHD death costs without screening.

Conclusions:

• Cholesterol screening programs can be evaluated using spreadsheet-based decision tree and sensitivity analyses.
• The 200-240 mg/dl range for serum cholesterol appears most cost-effective for screening initiation.
• Preliminary estimates suggest a modest but significant net benefit from implementing such a program.